EXCLUSIVE: Game-Changer In Cannabinoid Market? OBX Acquires Nucl3o

Open Book Extracts (OBX), a cannabinoid product manufacturer, has inked a term sheet to acquire Nucl3o, a processor of high-purity cannabinoid isolates, Benzinga Cannabis has learned exclusively. This acquisition marks a significant move in the cannabinoid industry, as it combines OBX's large-scale production capabilities with Nucl3o's expertise in cannabinoid ingredient manufacturing, elevating both companies' global distribution.

Who's Who

OBX, with its 76,000-square-foot facility near Durham, North Carolina, is known for its organic, kosher and halal-certified research and production. The company specializes in manufacturing cannabinoid ingredients and a variety of finished goods such as gummies, softgels, tinctures and beverage enhancers. Its approach includes concept-to-market formulation and product development, utilizing advanced water-soluble technology and unique delivery mechanisms.

Nucl3o, based in Nevada, has established itself as a leader in the production of hemp-derived cannabinoids. The company's integration with OBX aims to leverage their respective strengths in scaled production, quality assurance, and innovation. The combined entity plans to invest substantially in scaled production to meet the demands of its worldwide distribution channels.

The Next Step In A Strategic Plan

Dave Neundorfer, CEO of OBX expressed enthusiasm about the acquisition. “Having collaborated on complimentary parts of the supply chain to validate a combined value proposition, we are thrilled to officially join forces to bring the best-in-class, low-cost, highly quality ingredient production and finished good innovation and manufacturing to market.”

David Franco, CFO of Nucl3o highlighted the strategic significance of the partnership. “Teaming with OBX completes the next step in Nucl3o’s strategic plan. Our process of providing a consistent high-quality base product for the manufacturing sector has been our service goal. We look forward to expanding our production line to assist in providing the basis for high-quality finished good lines for the domestic and foreign markets.”

The deal between OBX and Nucl3o is a testament to the evolving landscape of the cannabinoid industry, signaling a trend toward consolidation and a heightened focus on quality and innovation in production methods.